BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 38600440)

  • 21. Comprehensive Analysis of the Potential Prognostic Value of 11 Glycosylation-Related Genes in Head and Neck Squamous Cell Carcinoma and Their Correlation with PD-L1 Expression and Immune Infiltration.
    Chen L; Ling Y; Yang H
    J Oncol; 2022; 2022():2786680. PubMed ID: 35466312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cisplatin overcomes radiotherapy resistance in OCT4-expressing head and neck squamous cell carcinoma.
    Routila J; Qiao X; Weltner J; Rantala JK; Carpén T; Hagström J; Mäkitie A; Leivo I; Ruuskanen M; Söderlund J; Rintala M; Hietanen S; Irjala H; Minn H; Westermarck J; Ventelä S
    Oral Oncol; 2022 Apr; 127():105772. PubMed ID: 35245886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lima1 mediates the pluripotency control of membrane dynamics and cellular metabolism.
    Duethorn B; Groll F; Rieger B; Drexler HCA; Brinkmann H; Kremer L; Stehling M; Borowski MT; Mildner K; Zeuschner D; Zernicka-Goetz M; Stemmler MP; Busch KB; Vaquerizas JM; Bedzhov I
    Nat Commun; 2022 Feb; 13(1):610. PubMed ID: 35105859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy.
    Xu Y; Gao Z; Hu R; Wang Y; Wang Y; Su Z; Zhang X; Yang J; Mei M; Ren Y; Li M; Zhou X
    J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34697216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanoparticle-Aided Detection of Colorectal Cancer-Associated Glycoconjugates of Extracellular Vesicles in Human Serum.
    Vinod R; Mahran R; Routila E; Leivo J; Pettersson K; Gidwani K
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer cell line microarray as a novel screening method for identification of radioresistance biomarkers in head and neck squamous cell carcinoma.
    Routila J; Suvila K; Grénman R; Leivo I; Westermarck J; Ventelä S
    BMC Cancer; 2021 Jul; 21(1):868. PubMed ID: 34320941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas.
    Lüttich L; Besso MJ; Heiden S; Koi L; Baumann M; Krause M; Dubrovska A; Linge A; Kurth I; Peitzsch C
    Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33919702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of potential glycoprotein biomarkers in oral squamous cell carcinoma using sweet strategies.
    Wong YL; Anand R; Yuen KM; Mustafa WMW; Abraham MT; Tay KK; Rahman ZAA; Chen Y
    Glycoconj J; 2021 Feb; 38(1):1-11. PubMed ID: 33547992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
    Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
    CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocyte Growth Factor Receptor overexpression predicts reduced survival but its targeting is not effective in unselected HNSCC patients.
    Khan M; Khaznadar SS; Routila J; Ventelä S; Schmid E; Gebhart B; Becker ET; Roider HG; Perala M; Schmitz AA; Krahn T; von Ahsen O
    Head Neck; 2020 Apr; 42(4):625-635. PubMed ID: 31919967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanoparticle-aided glycovariant assays to bridge biomarker performance and ctDNA results.
    Gidwani K; Kekki H; Terävä J; Soukka T; Sundfeldt K; Pettersson K
    Mol Aspects Med; 2020 Apr; 72():100831. PubMed ID: 31787337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein Paucimannosylation Is an Enriched N-Glycosylation Signature of Human Cancers.
    Chatterjee S; Lee LY; Kawahara R; Abrahams JL; Adamczyk B; Anugraham M; Ashwood C; Sumer-Bayraktar Z; Briggs MT; Chik JHL; Everest-Dass A; Förster S; Hinneburg H; Leite KRM; Loke I; Möginger U; Moh ESX; Nakano M; Recuero S; Sethi MK; Srougi M; Stavenhagen K; Venkatakrishnan V; Wongtrakul-Kish K; Diestel S; Hoffmann P; Karlsson NG; Kolarich D; Molloy MP; Muders MH; Oehler MK; Packer NH; Palmisano G; Thaysen-Andersen M
    Proteomics; 2019 Nov; 19(21-22):e1900010. PubMed ID: 31419058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lectin nanoparticle assays for detecting breast cancer-associated glycovariants of cancer antigen 15-3 (CA15-3) in human plasma.
    Terävä J; Tiainen L; Lamminmäki U; Kellokumpu-Lehtinen PL; Pettersson K; Gidwani K
    PLoS One; 2019; 14(7):e0219480. PubMed ID: 31344060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased maternal serum placental growth hormone variant in pregnancies complicated by otosclerosis.
    Liao S; Lu S; Li G; Chen R
    Clin Otolaryngol; 2019 Sep; 44(5):757-761. PubMed ID: 31148391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein glycosylation.
    Eichler J
    Curr Biol; 2019 Apr; 29(7):R229-R231. PubMed ID: 30939300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. O-GlcNAc transferase regulates transcriptional activity of human Oct4.
    Constable S; Lim JM; Vaidyanathan K; Wells L
    Glycobiology; 2017 Oct; 27(10):927-937. PubMed ID: 28922739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved cancer specificity in PSA assay using Aleuria aurantia lectin coated Eu-nanoparticles for detection.
    Kekki H; Peltola M; van Vliet S; Bangma C; van Kooyk Y; Pettersson K
    Clin Biochem; 2017 Jan; 50(1-2):54-61. PubMed ID: 27818346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources.
    Gidwani K; Huhtinen K; Kekki H; van Vliet S; Hynninen J; Koivuviita N; Perheentupa A; Poutanen M; Auranen A; Grenman S; Lamminmäki U; Carpen O; van Kooyk Y; Pettersson K
    Clin Chem; 2016 Oct; 62(10):1390-400. PubMed ID: 27540033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of artificial cancer stem cells from tongue cancer cells by defined reprogramming factors.
    Harada K; Ferdous T; Cui D; Kuramitsu Y; Matsumoto T; Ikeda E; Okano H; Ueyama Y
    BMC Cancer; 2016 Jul; 16():548. PubMed ID: 27464948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycosylation in cancer: mechanisms and clinical implications.
    Pinho SS; Reis CA
    Nat Rev Cancer; 2015 Sep; 15(9):540-55. PubMed ID: 26289314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.